Secondly, approximately 40% of patients with SLE are confirmed positive for anticardiolipin antibodies (aPL) and 50%-70% of these progress to secondary antiphospholipid syndrome (APS). The gene discussed is FASLG; the disease is systemic lupus erythematosus.